248 related articles for article (PubMed ID: 19302595)
21. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
Tan W; Sun J; Zhou L; Li Y; Wu X
J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
[TBL] [Abstract][Full Text] [Related]
22. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
23. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K
Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440
[TBL] [Abstract][Full Text] [Related]
24. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
[TBL] [Abstract][Full Text] [Related]
25. Do antiosteoporotic drugs improve bone regeneration in vivo?
Leiblein M; Henrich D; Fervers F; Kontradowitz K; Marzi I; Seebach C
Eur J Trauma Emerg Surg; 2020 Apr; 46(2):287-299. PubMed ID: 31028428
[TBL] [Abstract][Full Text] [Related]
26. Antiosteoporotic activity of Davallia formosana.
Ko YJ; Wu JB; Ho HY; Lin WC
J Ethnopharmacol; 2012 Jan; 139(2):558-65. PubMed ID: 22155390
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases.
Inoue Y; Shimojo N; Suzuki S; Arima T; Tomiita M; Minagawa M; Kohno Y
Clin Rheumatol; 2008 Jul; 27(7):909-12. PubMed ID: 18330609
[TBL] [Abstract][Full Text] [Related]
29. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
[TBL] [Abstract][Full Text] [Related]
30. The effects of weekly alendronate therapy in Taiwanese males with osteoporosis.
Hwang JS; Liou MJ; Ho C; Lin JD; Huang YY; Wang CJ; Tsai KS; Chen JF
J Bone Miner Metab; 2010 May; 28(3):328-33. PubMed ID: 20012918
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Clin Rheumatol; 2007 Feb; 26(2):161-7. PubMed ID: 16565894
[TBL] [Abstract][Full Text] [Related]
32. Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats.
Sung MJ; Davaatseren M; Hur HJ; Kim HJ; Ryu SY; Choi YH; Cha MR; Kwon DY
Phytother Res; 2012 Aug; 26(8):1182-8. PubMed ID: 22821855
[TBL] [Abstract][Full Text] [Related]
33. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
Li F; Yang X; Bi J; Yang Z; Zhang C
Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
[TBL] [Abstract][Full Text] [Related]
34. Low Doses of Simvastatin Potentiate the Effect of Sodium Alendronate in Inhibiting Bone Resorption and Restore Microstructural and Mechanical Bone Properties in Glucocorticoid-Induced Osteoporosis.
Sequetto PL; Gonçalves RV; Pinto AS; Oliveira MGA; Maldonado IRSC; Oliveira TT; Novaes RD
Microsc Microanal; 2017 Oct; 23(5):989-1001. PubMed ID: 28743325
[TBL] [Abstract][Full Text] [Related]
35. Prevention of corticosteroid-induced bone loss with alendronate.
Wimalawansa SJ; Simmons DJ
Proc Soc Exp Biol Med; 1998 Feb; 217(2):162-7. PubMed ID: 9452139
[TBL] [Abstract][Full Text] [Related]
36. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat.
Tezval M; Serferaz G; Rack T; Kolios L; Sehmisch S; Schmelz U; Tezval H; Stuermer KM; Stuermer EK
World J Urol; 2011 Aug; 29(4):529-34. PubMed ID: 21298272
[TBL] [Abstract][Full Text] [Related]
37. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
Khan MP; Singh AK; Singh AK; Shrivastava P; Tiwari MC; Nagar GK; Bora HK; Parameswaran V; Sanyal S; Bellare JR; Chattopadhyay N
J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
[TBL] [Abstract][Full Text] [Related]
38. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine.
Ren H; Shen G; Tang J; Qiu T; Zhang Z; Zhao W; Yu X; Huang J; Liang D; Yao Z; Yang Z; Jiang X
Sci Rep; 2017 Sep; 7(1):10617. PubMed ID: 28878388
[TBL] [Abstract][Full Text] [Related]
39. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM
N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805
[TBL] [Abstract][Full Text] [Related]
40. Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract.
Qi W; Yan YB; Lei W; Wu ZX; Zhang Y; Liu D; Shi L; Cao PC; Liu N
Osteoporos Int; 2012 Sep; 23(9):2347-57. PubMed ID: 22159671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
